Earlier this month, Vimizim was also approved in Australia for the treatment of this rare, severely debilitating and progressive disease that previously had no approved, standard-of-care treatment other
ZipDose products allow people to take their medications with greater ease, potentially increasing adherence and improving symptom management. According to the company, these products achieve dosage strengths that
A total of 46 male and female volunteers ranging from 45 to 80 years of age were included in the randomized, double-blind, placebo-controlled cross-over trial. The company said
The research alliance will focus on discovery, research and development of new drugs for some of the common and debilitating gastrointestinal diseases and disorders such as irritable bowel
The product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a
The five-year distribution deal gives FastFunds exclusive distribution rights in the marijuana market segment in the US. The marijuana market segment includes all 50 states, but only applies
Moventig is the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) to be approved in the European Union (EU). The approval was based on data from the KODIAC
The three parties will jointly develop and conduct research projects in health outcomes and real-world evidence in areas of mutual interest. Under the deal, each company will bring
Both the firms will jointly work on a worldwide basis with the aim of bringing an important investigational therapy to patients. Pfizer senior vice president and chief scientific
PXVX0200 uses the same attenuated vaccine strain (CVD 103-HgR) previously approved and marketed in several countries under the brand name Orochol. The company plans to submit a Biologics
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.